JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB221569

Anti-START domain containing 7 抗体

Anti-START domain containing 7 antibody

Be the first to review this product! Submit a review

|

(1 Publication)

Rabbit Polyclonal START domain containing 7 antibody. Suitable for ICC/IF and reacts with Human samples. Cited in 1 publication. Immunogen corresponding to Recombinant Fragment Protein within Human STARD7 aa 250 to C-terminus.

別名を表示する

GTT1, STARD7, Gestational trophoblastic tumor protein 1, START domain-containing protein 7, StARD7

1 Images
Immunocytochemistry/ Immunofluorescence - Anti-START domain containing 7 antibody (AB221569)
  • ICC/IF

Supplier Data

Immunocytochemistry/ Immunofluorescence - Anti-START domain containing 7 antibody (AB221569)

PFA-fixed, Triton X-100 permeabilized U-2 OS (human bone osteosarcoma epithelial cell line) cells stained for START domain containing 7 (green) using ab221569 at 4 μg/ml in ICC/IF.

Key facts

宿主種

Rabbit

クローン性

Polyclonal

アイソタイプ

IgG

キャリアフリー

No

交差種

Human

アプリケーション

ICC/IF

applications

免疫原

Recombinant Fragment Protein within Human STARD7 aa 250 to C-terminus. The exact immunogen used to generate this antibody is proprietary information.

Q9NQZ5

Reactivity data

{ "title": "Reactivity Data", "filters": { "stats": ["", "Species", "Dilution Info", "Notes"], "tabs": { "all-applications": {"fullname" : "All Applications", "shortname": "All Applications"}, "ICCIF" : {"fullname" : "Immunocytochemistry/ Immunofluorescence", "shortname":"ICC/IF"} }, "product-promise": { "all": "all", "testedAndGuaranteed": "tested", "guaranteed": "expected", "predicted": "predicted", "notRecommended": "not-recommended" } }, "values": { "Human": { "ICCIF-species-checked": "testedAndGuaranteed", "ICCIF-species-dilution-info": "0.25-2 µg/mL", "ICCIF-species-notes": "<p>Fixation/Permeabilization: PFA/Triton X-100.</p>" }, "Mouse": { "ICCIF-species-checked": "predicted", "ICCIF-species-dilution-info": "", "ICCIF-species-notes": "" }, "Rat": { "ICCIF-species-checked": "predicted", "ICCIF-species-dilution-info": "", "ICCIF-species-notes": "" } } }

出荷温度及び保存条件

製品の状態
Liquid
精製方法
Affinity purification Immunogen
バッファー組成
pH: 7.2 Preservative: 0.02% Sodium azide Constituents: PBS, 40% Glycerol (glycerin, glycerine)
出荷温度
Blue Ice
短期保存期間
1-2 weeks
短期保存温度
+4°C
長期保存温度
-20°C
分注に関する情報
Upon delivery aliquot
保管に関する情報
Avoid freeze / thaw cycle

補足情報

This supplementary information is collated from multiple sources and compiled automatically.

START domain containing 7 (STARD7) also known as StAR-related lipid transfer protein 7 is a protein involved in lipid transfer and metabolism. It is approximately 37 kDa in mass. STARD7 facilitates the movement of phospholipids between membranes playing a role in maintaining cellular lipid balance. The protein is broadly expressed in various tissues including liver kidney and the gastrointestinal tract indicating its widespread functional importance in the body.
Biological function summary

The lipid transport function of STARD7 contributes to maintaining membrane integrity and cellular homeostasis. It is involved in intracellular lipid signaling pathways impacting diverse cellular processes. STARD7 does not form a part of large protein complexes but functions alongside other lipid transfer proteins helping to regulate levels of important lipids in the cell. Its activity impacts cellular processes that rely on dynamic membrane composition and signaling lipid availability.

Pathways

STARD7 participates in the lipid signaling and transport pathways. It acts within the phosphatidylcholine transfer pathway cooperating with phosphatidylcholine transfer proteins. This activity links STARD7 closely with lipid metabolism pathways and phospholipid transfer cycles that are central to cellular energy homeostasis and membrane dynamics. These pathways often connect with broader metabolic processes influenced by related proteins such as STARD5.

Dysfunction of STARD7 associates with metabolic syndromes and gastrointestinal diseases. Altered lipid transfer due to problems in STARD7 expression or function has implications in obesity-related metabolic disruption. It is also linked to inflammatory bowel diseases where lipid homeostasis plays a part in intestinal inflammation and immune responses. In these conditions STARD7 interacts with proteins involved in lipid metabolism and inflammatory signaling such as LXR receptors which further influence disease progression and patient outcomes.

製品プロトコール

For this product, it's our understanding that no specific protocols are required. You can visit:

ターゲットの情報

May play a protective role in mucosal tissues by preventing exaggerated allergic responses.
See full target information STARD7

文献 (1)

Recent publications for all applications. Explore the full list and refine your search

Translational oncology 26:101562 PubMed36228410

2022

ARNTL2 is an indicator of poor prognosis, promotes epithelial-to-mesenchymal transition and inhibits ferroptosis in lung adenocarcinoma.

Applications

Unspecified application

Species

Unspecified reactive species

Huan Zhang,Guangyao Shan,Xing Jin,Xiangyang Yu,GuoShu Bi,Mingxiang Feng,Hao Wang,Miao Lin,Cheng Zhan,Qun Wang,Ming Li
View all publications

Abcam product promise

当社は、高品質な試薬を通じてお客様の研究を力強くサポートすることをお約束いたします。ご使用いただく各段階で、常にお客様をサポートできる体制を整えております。万が一、製品が期待通りに機能しない場合は、「Abcam Product Promise」による当社保証制度に基づき、安心してご利用いただけます。
保証に関する詳細については利用規約をご確認ください。

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com